The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Optimizing biomarker testing and targeted therapy integration in early-stage NSCLC: A quality improvement initiative at community oncology clinics.
 
Mary Fidler
Honoraria - Daiichi Sankyo/Astra Zeneca; EMD Serono
Consulting or Advisory Role - Abbvie; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb/Pfizer; Daiichi Sankyo/Astra Zeneca; Genentech; Gilead Sciences; Lilly; Merus; Novocure; Oncohost; Proventus Group; Tempus
Speakers' Bureau - EMD Serono
Research Funding - AstraZeneca (Inst); Daiichi Sankyo/Astra Zeneca (Inst); Genentech (Inst); Gilead Sciences (Inst); Iovance Biotherapeutics (Inst); Merck (Inst); Novartis (Inst); Pfizer/EMD Serono
 
Janet Storey
No Relationships to Disclose
 
Ilona Dewald
No Relationships to Disclose
 
Samuel Dooyema
No Relationships to Disclose
 
Jeffrey Carter
No Relationships to Disclose
 
Cherilyn Heggen
No Relationships to Disclose
 
Kelly McKinnon
No Relationships to Disclose